The Role of Rasagiline in Non-Motor Parkinson's Disease Symptoms
In my recent research, I came across the role of Rasagiline in managing non-motor symptoms of Parkinson's Disease. It turns out that Rasagiline, a monoamine oxidase type B (MAO-B) inhibitor, is not only effective in slowing down the motor-related symptoms but also improving non-motor symptoms like fatigue, mood disorders, and cognitive decline. This medication is often used alongside other treatments for a more comprehensive approach in managing Parkinson's Disease. I found it fascinating how this drug can make a significant impact on patients' quality of life by addressing these non-motor symptoms. It's essential to spread awareness about Rasagiline's potential benefits in managing this complex condition.
